C. Durant

2.0k total citations
56 papers, 494 citations indexed

About

C. Durant is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, C. Durant has authored 56 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Pathology and Forensic Medicine and 15 papers in Rheumatology. Recurrent topics in C. Durant's work include Systemic Sclerosis and Related Diseases (13 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Vasculitis and related conditions (9 papers). C. Durant is often cited by papers focused on Systemic Sclerosis and Related Diseases (13 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Vasculitis and related conditions (9 papers). C. Durant collaborates with scholars based in France, Canada and United States. C. Durant's co-authors include M. Hamidou, Dominique Farge, B. Hervier, J. Connault, P. Debourdeau, C. Agard, B. Planchon, Olivier Espitia, Marc‐Antoine Pistorius and Zahir Amoura and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Medicine.

In The Last Decade

C. Durant

50 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Durant France 13 191 130 118 85 85 56 494
C.Y. Maximilian Png United States 15 143 0.7× 32 0.2× 100 0.8× 189 2.2× 15 0.2× 56 726
Annalisa Orenti Italy 16 140 0.7× 22 0.2× 50 0.4× 88 1.0× 116 1.4× 52 551
Se Hwan Kwon South Korea 13 176 0.9× 31 0.2× 102 0.9× 471 5.5× 32 0.4× 62 720
Ross O. Hill Canada 7 99 0.5× 187 1.4× 52 0.4× 306 3.6× 130 1.5× 8 1.1k
Tsutomu Minamikawa Japan 20 169 0.9× 33 0.3× 35 0.3× 412 4.8× 33 0.4× 71 904
Дејан Трајков North Macedonia 11 44 0.2× 82 0.6× 18 0.2× 28 0.3× 25 0.3× 40 433
Mehmet Ruhi Onur Türkiye 16 197 1.0× 56 0.4× 18 0.2× 295 3.5× 15 0.2× 57 716
Gal Goldstein Israel 13 78 0.4× 30 0.2× 67 0.6× 72 0.8× 20 0.2× 44 511
Barry Leshin United States 20 85 0.4× 109 0.8× 40 0.3× 248 2.9× 183 2.2× 45 1.0k
Franziska Peters Germany 9 28 0.1× 33 0.3× 169 1.4× 102 1.2× 4 0.0× 26 449

Countries citing papers authored by C. Durant

Since Specialization
Citations

This map shows the geographic impact of C. Durant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Durant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Durant more than expected).

Fields of papers citing papers by C. Durant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Durant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Durant. The network helps show where C. Durant may publish in the future.

Co-authorship network of co-authors of C. Durant

This figure shows the co-authorship network connecting the top 25 collaborators of C. Durant. A scholar is included among the top collaborators of C. Durant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Durant. C. Durant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durant, C., et al.. (2023). Atteinte digestive de la sclérodermie systémique. La Revue de Médecine Interne. 44(8). 410–422. 3 indexed citations
2.
Frère, Corinne, Benjamin Crichi, J. Connault, et al.. (2022). The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis. Journal of Clinical Medicine. 11(13). 3729–3729. 3 indexed citations
3.
Durant, C., et al.. (2022). Thoracic lymphadenopathies in diffuse systemic sclerosis: an observational study on 48 patients using computed tomography. BMC Pulmonary Medicine. 22(1). 44–44. 3 indexed citations
4.
Espitia, Olivier, Gauthier Blonz, G. Urbanski, et al.. (2021). Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event. Arthritis Research & Therapy. 23(1). 14–14. 33 indexed citations
5.
Mauhin, Wladimir, Guillaume Michel, C. Durant, et al.. (2021). Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY. European Archives of Oto-Rhino-Laryngology. 279(3). 1639–1644. 2 indexed citations
6.
Lamirault, Guillaume, J. Connault, C. Durant, et al.. (2021). Évaluation d’un parcours de soin chez la femme au décours d’une prééclampsie. La Revue de Médecine Interne. 42(3). 154–161.
7.
Dirou, S., et al.. (2018). Radiological pleuroparenchymal fibroelastosis associated to limited cutaneous systemic sclerosis: a case report. BMC Pulmonary Medicine. 18(1). 73–73. 6 indexed citations
8.
Espitia, Olivier, J. Connault, C. Durant, et al.. (2017). Sclérodermie systémique de révélation tardive : étude rétrospective de 27 patients diagnostiqués après l’âge de 70 ans. Annales de Dermatologie et de Vénéréologie. 145(3). 166–172. 2 indexed citations
9.
Najm, Aurélie, Benoît Le Goff, Olivier Espitia, et al.. (2016). Trois observations de rhumatisme de Jaccoud au cours de la sclérodermie systémique. La Revue de Médecine Interne. 37(10). 708–713. 1 indexed citations
10.
Sevestre, Marie‐Antoinette, C. Bélizna, C. Durant, et al.. (2014). Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: The CARMEN study. Journal des Maladies Vasculaires. 39(3). 161–168. 42 indexed citations
11.
Barbarot, S., A. Néel, J. Connault, et al.. (2013). Manifestations cutanées associées aux gammapathies monoclonales. La Revue de Médecine Interne. 35(1). 28–38. 1 indexed citations
12.
13.
Durant, C., Johan van der Lei, Anne‐Sophie Moreau, et al.. (2012). La Schtroumpfette en Australie. La Revue de Médecine Interne. 33(9). 536–538.
14.
Hervier, B., M. Hamidou, Julien Haroche, et al.. (2011). Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?. Rheumatology International. 32(10). 3285–3290. 45 indexed citations
15.
Bras, M. Le, B. Hervier, A. Masseau, et al.. (2010). Sarcoïdose systémique au décours d’un traitement par interféron-alpha pégylé. La Revue de Médecine Interne. 31(4). e11–e13. 2 indexed citations
16.
Vincent, C., C. Agard, S. Barbarot, et al.. (2010). Les manifestations buccofaciales de la sclérodermie systémique : étude de 30 patients consécutifs. Revue de Stomatologie et de Chirurgie Maxillo-faciale. 111(3). 128–134. 14 indexed citations
17.
Farge, Dominique, C. Durant, Stéphane Villiers, et al.. (2010). Lessons from French national guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients. Thrombosis Research. 125. S108–S116. 35 indexed citations
18.
Durant, C., et al.. (2010). Juvenile Temporal Vasculitis: A Rare Case in a Middle-Aged Woman. Annals of Vascular Surgery. 25(3). 384.e5–384.e7. 8 indexed citations
19.
Durant, C., et al.. (2009). Syndrome pied-main nécrotique sous antiangiogéniques chez une patiente porteuse d’une acropathie ulcéromutilante de Thévenard. Journal des Maladies Vasculaires. 34(3). 222–225. 4 indexed citations
20.
Vincent, C., C. Agard, S. Barbarot, et al.. (2008). Les manifestations buccofaciales de la sclérodermie systémique : étude de 30 patients consécutifs. La Revue de Médecine Interne. 30(1). 5–11. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.Y. Maximilian Png Breakdown of academic impact, for papers by Annalisa Orenti Breakdown of academic impact, for papers by Se Hwan Kwon Breakdown of academic impact, for papers by Ross O. Hill Breakdown of academic impact, for papers by Tsutomu Minamikawa Breakdown of academic impact, for papers by Дејан Трајков Breakdown of academic impact, for papers by Mehmet Ruhi Onur Breakdown of academic impact, for papers by Gal Goldstein Breakdown of academic impact, for papers by Barry Leshin Breakdown of academic impact, for papers by Franziska Peters
Rankless by CCL
2026